The Food and Drug Administration's (FDA) upcoming Vaccine and Related Biological Products Advisory Committee meeting on March 13 was abruptly canceled via email on Wednesday. The committee was to consider the selection of strains to be included in the influenza virus vaccines for the 2025–2026 flu season. This is the second vaccine-related advisory meeting canceled since Robert F. Kennedy, Jr. took over at the Department of Health and Human Services (HHS).
No reason for the cancellation was given, and the committee members were warned against forwarding the email. It suggested that members decline to answer questions from media.
So much for Kennedy's pledge earlier this month of "radical transparency." He added, "We will make our data and our policy process so transparent that people won't even have to file a FOIA [Freedom of Information Act] request."
